Clinical Research Directory

Inclusion Criteria: * Written informed consent signed voluntarily according to the rules of good clinical practice (Declaration of Helsinki) and national regulations (Appendix B). * Genetically male patient. * Age ≥ 18 years. * Patient suffering from ED of variable and/or multifactorial etiology. * Patient suffering from ED not responsive to iPDE-5. * Patient suffering from unresponsive or non-tolerant ED Exclusion Criteria: * Absence of signed written informed consent (Appendix B). * Age \<18 years. * Genetically female patients. * Patient with active peno-scrotal infection. * Patient with active systemic infection. * Immunosuppressed patient. * Patient with haematological pathologies that may cause an increased risk of bleeding. * Patients suffering from Peyronie's Disease who must undergo simultaneous plaque surgery. * Any condition or situation that, in the opinion of the investigator, places the patient at significant risk, may confound the results of the study, or significantly interfere with the patient's participation in the study. * The patient declares that it will be impossible for him to participate in follow-up consultations.